Prenetics Global Limited
PRE
$17.47
-$2.28-11.54%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2,737.29% | 98.74% | -27.69% | -108.71% | -93.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2,737.29% | 98.74% | -27.69% | -108.71% | -93.88% |
| Cost of Revenue | 627.14% | 145.57% | -50.07% | -150.02% | -90.19% |
| Gross Profit | 401.12% | 50.34% | 15.92% | -61.81% | -96.47% |
| SG&A Expenses | 163.06% | 103.33% | -25.37% | -70.96% | -51.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -73.35% | -70.25% | 110.51% | 166.97% | -290.83% |
| Total Operating Expenses | 288.71% | 71.00% | -26.81% | -72.72% | -71.34% |
| Operating Income | -20.19% | -58.72% | 26.47% | 56.94% | -174.00% |
| Income Before Tax | -43.18% | -70.57% | 17.87% | 67.06% | -5.20% |
| Income Tax Expenses | -34.53% | -67,586.36% | 178.26% | 208.19% | -100.33% |
| Earnings from Continuing Operations | -42.20% | -19.77% | 17.71% | 66.51% | 19.55% |
| Earnings from Discontinued Operations | 20.38% | 100.12% | -5.24% | -30.46% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.15% | 111.36% | 173.53% | 5.90% | -- |
| Net Income | -15.74% | 3.57% | 21.36% | 50.83% | 8.91% |
| EBIT | -20.19% | -58.72% | 26.47% | 56.94% | -174.00% |
| EBITDA | -16.72% | -67.18% | 32.61% | 59.81% | -166.41% |
| EPS Basic | -6.79% | 8.84% | 27.41% | 57.37% | 63.61% |
| Normalized Basic EPS | -42.01% | -100.66% | -- | -- | -- |
| EPS Diluted | -6.79% | 12.61% | 27.48% | 57.43% | 63.60% |
| Normalized Diluted EPS | -42.01% | -100.66% | -- | -- | -- |
| Average Basic Shares Outstanding | 8.39% | 5.77% | 8.34% | 15.33% | 150.32% |
| Average Diluted Shares Outstanding | 8.39% | 5.77% | 8.34% | 15.33% | 150.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |